Celiac Disease and Risk of Liver Disease: a General Population-based Study
Overview
Affiliations
Background & Aims: Celiac disease (CD) is an important cause of hypertransaminasemia. CD might also be associated with severe forms of liver disease. We investigated the risk of liver disease in 13,818 patients with CD (1964-2003) and 66,584 age- and sex-matched reference individuals from a general population cohort.
Methods: We used Cox regression to estimate hazard ratios (HRs) for later liver disease and conditional logistic regression to estimate the risk of CD in individuals with liver disease before study entry.
Results: CD was associated with an increased risk of acute hepatitis (HR, 5.21; 95% confidence interval [CI], 1.88-14.40; P = .001), chronic hepatitis (HR, 5.84; 95% CI, 2.89-11.79; P < .001), primary sclerosing cholangitis (HR, 4.46; 95% CI, 2.50-7.98; P < .001), fatty liver (HR, 6.06; 95% CI, 1.35-27.16; P = .018), liver failure (HR, 3.30; 95% CI, 2.22-4.88; P < .001), liver cirrhosis or liver fibrosis (HR, 2.23; 95% CI, 1.34-3.72; P < .001), and primary biliary cirrhosis (HR, 10.16; 95% CI, 2.61-39.49; P < .001). There was no increased risk of liver transplantation (HR, 1.07; 95% CI, 0.12-9.62; P = .954). Adjustment for socioeconomic index or diabetes mellitus had no notable effect on the risk estimates. Prior liver disease was associated with a statistically significant 4-fold to 6-fold increased risk of later CD.
Conclusion: This study suggests that individuals with CD are at increased risk of both prior and subsequent liver disease.
Seidita A, Latteri F, Pistone M, Giuliano A, Bertoncello L, Cavallo G Nutrients. 2025; 17(1.
PMID: 39796519 PMC: 11722968. DOI: 10.3390/nu17010085.
Postbiotics: As a Promising Tools in the Treatment of Celiac Disease.
Khani N, Bonyadi M, Soleimani R, Raziabad R, Ahmadi M, Homayouni-Rad A Probiotics Antimicrob Proteins. 2024; .
PMID: 39673575 DOI: 10.1007/s12602-024-10416-y.
Severe Liver Damage in an Obese Patient: Onset of Celiac Disease or Overlap Syndrome?.
Ghiga G, Boca L, Cojocaru E, Starcea I, Tarca E, Scurtu A Diagnostics (Basel). 2024; 14(16).
PMID: 39202320 PMC: 11353973. DOI: 10.3390/diagnostics14161832.
Celiac Disease, Gluten-Free Diet and Metabolic Dysfunction-Associated Steatotic Liver Disease.
Cazac G, Mihai B, Stefanescu G, Gilca-Blanariu G, Mihai C, Grigorescu E Nutrients. 2024; 16(13).
PMID: 38999756 PMC: 11243569. DOI: 10.3390/nu16132008.
Fatty liver disease that is neither metabolic nor alcoholic.
Allende D, Kleiner D Hum Pathol. 2023; 141:212-221.
PMID: 36702356 PMC: 10363575. DOI: 10.1016/j.humpath.2023.01.003.